World's most-common bleeding disorder targeted with $90M raise

The company, launched in 2018, is creating spinouts focused on specific rare diseases.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 5, 2023 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news